Recent share performance and business snapshot ACADIA Pharmaceuticals (ACAD) has attracted attention after a weak spell in the stock, with shares showing declines over the past week, month and past 3 ...

Frontotemporal dementia (FTD), in particular, may be at play, and identifying ways to slow down its progression can help. In ...

The big thinkers at Aperture warn how AI is driving mass psychosis.

Axsome's lead product, Auvelity, sales jumped 74% to $507M in 2025, fueling growth while other drugs added momentum.

Scientists have achieved a significant breakthrough in Parkinson’s research, developing a novel technique that can detect tiny brain clusters believed to trigger the debilitating disease. A hallmark ...

DE PERE, Wis. (WFRV) – Officers are currently looking for a missing woman from De Pere who was reportedly last seen on March 6 and is 15 weeks pregnant. According to a statewide missing persons ...

Bristol Myers Squibb’sBMY boasts a deep and promising pipeline. Key pipeline candidates with multi-billion-dollar potential are milvexian (Oral factor XIa inhibitor), admilparant (LPA1 antagonist) ...

How can we explain the onset of psychotic symptoms characteristic of schizophrenia? Despite their major and often irreversible impact on intellectual abilities and autonomy, the biological mechanisms ...

A new clinic-ready web-based risk prediction tool called PsyMetRiC is now available to forecast the risk of young people with ...

Springtime in Pennsylvania is peanut butter egg season. This year some consumers may taste the eggs a bit more critically and scrutinize the ingredients and label more carefully. Reese’s, a Hershey ...

ACADIA Pharmaceuticals (NASDAQ:ACAD) highlighted its growing commercial portfolio, upcoming clinical catalysts, and cash position during a presentation at the Citizens Life Sciences Conference, with ...

Since the 2010s, breakthroughs in AI have prompted discussion about their implications for work, including a possible ...